This score includes independent predictors of recurrence, such as CEA levels ≥200 ng/mL, disease-free interval <12 months, multiple tumors, tumor size >5 cm, and lymph node metastasis in CRC [10]. The gene discussed is CEACAM5; the disease is metastatic malignant neoplasm in the lymph nodes.